Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: Long-term results

Neurological Sciences

Volumn 28, Issue 3, 2007, Pages 127-132

  Ghezzi, Angelo ^a   Amato, M P ^b   Capobianco, M ^c   Gallo, P ^d   Marrosu, M G ^e   Martinelli, V ^f   Milanese, C ^g   Moiola, L ^f   Milani, N ^g   Mantia, L ^g   Patti, F ^h   Pozzilli, C ⁱ   Trojano, M ^j   Comi, G ^f   Simone, I L ^j   Bellacosa, A ^j   Ardito, R ^k   Stecchi, S ^l   Scandellari, C ^l   Spinicci, G ^e   Cristaldi, A ^h   Portaccio, E ^b   Lori, S ^m   Costantino, G F ⁿ   Pilato, V ^a   Zaffaroni, M ^a   Bellantonio, A ^o   Fantozzi, F ^o   Scarpini, E ^p   De Riz, M ^p   Merelli, E ^q   Guerra, A ^q   Perini, P ^d   Atzori, M ^d   Bergamaschi, R ^r   Veggiotti, P ^r   Prosperini, L ⁱ   Bertolotto, A ^c   Malucchi, S ^c   Cavalla, P ^s   more..

^a Centro Studi Sclerosi Multipla   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SAN LUIGI GONZAGA HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF CAGLIARI   (Italy)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g DEPARTMENT OF NEUROSURGERY   (Italy)

^h UNIVERSITY OF CATANIA   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j UNIVERSITY OF BARI   (Italy)

^k Dipartimento di Scienze Neurologiche e Psichiatriche   (Italy)

^l Centro Sclerosi Multipla   (Italy)

^m UNIVERSITY OF FLORENCE   (Italy)

ⁿ UO Neurologia   (Italy)

^o IRCCS NEUROMED   (Italy)

^p UNIVERSITY OF MILAN   (Italy)

^q Clinica Neurologica   (Italy)

^r C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^s UNIVERSITY OF TURIN   (Italy)

more..

Author keywords

Adolescence; Childhood; Immunomodulators; Interferon beta 1a; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; IMMUNOGLOBULIN; MITOXANTRONE;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FEMALE; FLU LIKE SYNDROME; HUMAN; LEUKOPENIA; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; MYALGIA; NAUSEA AND VOMITING; ONSET AGE; PATIENT COMPLIANCE; RECURRENCE RISK; SCHOOL CHILD; SIDE EFFECT; SKIN MANIFESTATION; THYROXINE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 34447251273     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-007-0804-2     Document Type: Article

References (16)

1. Ozakbas S, Idiman E, Balkan B, Yulug B (2003) Childhood and juvenile onset multiple sclerosis: Clinical and paraclinical features. Brain Dev 25:233-236
2. Pinhas-Hamiel O, Sarova-Pinhas I, Achiron A (2001) Multiple sclerosis in childhood and adolescence: Clinical features and management. Paediatr Drugs 3:329-336
3. Boiko A, Vorobeychik G, Paty D et al (2002) Early onset multiple sclerosis: A longitudinal study. Neurology 59:1006-1010
4. Simone IL, Carrara D, Tortorella C et al (2002) Course and prognosis in early onset MS: Comparison with adult-onset forms. Neurology 59:1922-1928
5. Goodin DS, Frohman EM, Garmany GP et al, and the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines (2002) Disease modifying therapies in multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 58:169-178
6. Banwell B, Reder AT, Krupp L et al (2006) Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology 66:472-476
7. Tenembaum SN, Segura MJ (2006) Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis. Neurology 67:511-513
8. Ghezzi A, Amato MP, Capobianco M et al and the Immunomodulatory Treatment of Early Onset MS Group (2005) Disease modifying drugs in childhood-juvenile multiple sclerosis: Results of an Italian co-operative study. Mult Scler 11:420-424
9. Ghezzi A, on behalf of the Immunomodulatory Treatment of Early Onset MS ITEMS Group (2005) Immunomodulatory treatment of early onset MS: Results of an Italian co-operative study. Neurol Sci 26[Suppl 4]:S183-S186
10. Lublin F, Reingold SC (1996) Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
11. McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121-127
12. Pohl D, Rostasy K, Gartner J, Hanefeld F (2005) Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology 64:888-890
13. Ghezzi A, Pozzilli C, Liguori M et al (2002) Prospective study of multiple sclerosis with early onset. Mult Scler 8:115-118
14. Jacobs LD, Cookfair DL, Rudick RA et al (1996) Intramuscular interferon-beta1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol 39:285-294
15. Filippini G, Munari L, Incorvaia B et al (2003) Interferons in relapsing remitting multiple sclerosis: A systematic review. Lancet 361:545-552
16. Gusev E, Boiko A, Bikova O et al (2002) The natural history of early onset multiple sclerosis: Comparison of data from Moscow and Vancouver. Clin Neurol Neurosurg 104:203-207